Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.0B | $2.4B | $2.5B | $3.0B | $3.4B | $3.4B |
| Gross profit | $939.8M | $1.2B | $1.3B | $1.5B | $1.6B | $1.6B |
| Operating income | $248.3M | $413.3M | $432.7M | $436.9M | $253.1M | $68.2M |
| Net income | $157.8M | $280.6M | $298.5M | $428.5M | $113.8M | -$8.3M |
| Diluted EPS | $1.02 | $1.81 | $1.99 | $2.90 | $0.76 | -$0.15 |
| Operating cash flow | $332.2M | $282.4M | $274.4M | $350.1M | $251.3M | $134.1M |
| Free cash flow | $235.0M | $190.4M | $145.2M | $243.2M | $136.0M | $43.3M |
| Gross margin | 47.3% | 50.0% | 51.6% | 51.0% | 49.0% | 45.9% |
| Operating margin | 12.5% | 17.1% | 17.1% | 14.7% | 7.5% | 2.0% |
| Net margin | 7.9% | 11.6% | 11.8% | 14.5% | 3.4% | -0.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $800.7M | $864.4M | $979.6M | $801.4M | $797.4M | $860.5M | $977.2M | $823.4M |
| Gross profit | $384.6M | $418.8M | $493.3M | $391.2M | $357.9M | $379.4M | $449.2M | $379.8M |
| Operating income | $48.1M | $68.1M | $72.1M | $31.8M | $11.9M | -$51.8M | $76.3M | $10.2M |
| Net income | $7.6M | $40.9M | $14.4M | $17.4M | $7.6M | -$59.6M | $26.3M | $14.4M |
| Diluted EPS | $0.05 | $0.27 | $0.09 | $0.11 | $0.05 | -$0.41 | $0.10 | $0.02 |
| Operating cash flow | $1.1M | $38.4M | $190.0M | $65.0M | -$127.5M | -$33.2M | $229.8M | $71.2M |
| Free cash flow | -$23.5M | $5.8M | $153.3M | $39.0M | -$148.8M | -$54.1M | $207.2M | $47.0M |
| Gross margin | 48.0% | 48.4% | 50.4% | 48.8% | 44.9% | 44.1% | 46.0% | 46.1% |
| Operating margin | 6.0% | 7.9% | 7.4% | 4.0% | 1.5% | -6.0% | 7.8% | 1.2% |
| Net margin | 0.9% | 4.7% | 1.5% | 2.2% | 1.0% | -6.9% | 2.7% | 1.7% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $60.25 | $120,500.00 | filing |
| 2026-07-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 | $44,380.00 | filing |
| 2026-06-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $54.76 | $109,520.00 | filing |
| 2026-06-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 | $44,380.00 | filing |
| 2026-05-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $43.90 | $87,800.00 | filing |
| 2026-05-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 | $44,380.00 | filing |
| 2026-05-15 | Bernard Thierry | Award | 2,886 | $0.00 | $0.00 | filing |
| 2026-04-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $39.90 | $79,800.00 | filing |
| 2026-04-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 | $44,380.00 | filing |
| 2026-03-13 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $35.44 | $70,880.00 | filing |
| 2026-03-13 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 | $44,380.00 | filing |
| 2026-02-15 | Bures Thomas· Chief Accounting Officer | Tax withholding | 274 | $36.51 | $10,003.74 | filing |
| 2026-02-15 | Phillips Jack | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | Friend Cynthia M | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | FRANCIS LAURA | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | ORNELL JOHN A | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | LINTON WILLIAM A | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | PACKER RICHARD A | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | Perkins Adelene Q | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | ROSENTHAL BOB | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | Requardt Hermann Fritz | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-15 | Anderson Bonnie H | Award | 4,520 | $0.00 | $0.00 | filing |
| 2026-02-13 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $36.94 | $73,880.00 | filing |
| 2026-02-13 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 | $44,380.00 | filing |
| 2026-01-15 | Munch Mark· EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $49.20 | $98,400.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.